Compare HRMY & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | LMAT |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2020 | 2006 |
| Metric | HRMY | LMAT |
|---|---|---|
| Price | $38.49 | $86.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $51.33 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 779.7K | 211.9K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 50.44 | 27.40 |
| EPS | ★ 3.17 | 2.32 |
| Revenue | ★ $825,944,000.00 | $240,866,000.00 |
| Revenue This Year | $23.11 | $15.17 |
| Revenue Next Year | $16.15 | $9.07 |
| P/E Ratio | ★ $11.94 | $36.62 |
| Revenue Growth | ★ 21.13 | 13.07 |
| 52 Week Low | $25.52 | $71.42 |
| 52 Week High | $40.93 | $105.55 |
| Indicator | HRMY | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 55.08 |
| Support Level | $37.12 | $82.52 |
| Resistance Level | $40.87 | $87.09 |
| Average True Range (ATR) | 1.38 | 2.49 |
| MACD | -0.33 | 0.40 |
| Stochastic Oscillator | 50.62 | 68.36 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.